急性呼吸窘迫综合征
FOXP3型
促炎细胞因子
胞外囊泡
医学
免疫学
免疫系统
脂多糖
炎症
急性呼吸窘迫
肺
细胞外小泡
微泡
癌症研究
白细胞介素
过继性细胞移植
先天免疫系统
转录因子
肿瘤坏死因子α
肺水肿
呼吸系统
细胞外
细胞因子
作者
Xu Liu,Wei Huang,Xiwen Zhang,Shiming Li,Haofei Wang,Zongsheng Wu,Shuangfeng Zi,Lu Wang,Ling Liu,Yi Yang,Jianfeng Xie,Mingzhu Zheng,Jie Chao,Haibo Qiu
摘要
Decreased percentage of Foxp3 + regulatory T cells (Tregs) in the lungs results in overwhelming inflammation and delayed recovery of acute lung injury (ALI) caused by acute respiratory distress syndrome (ARDS). Extracellular vesicles (EVs) in the pulmonary microenvironment significantly affect the immune system, but their underlying effects on Tregs are unclear. Here, we demonstrate increased endothelial cell‐derived EVs (CD31 + EVs) in lipopolysaccharide (LPS)‐induced ALI models by single‐EV analysis. EVs from activated pulmonary endothelial cells (ECs) exhibit proinflammatory effects and suppress Treg induction. Exposure of Tregs to these EVs induces massive production of interleukin (IL)‐21, which has been proven to reduce Foxp3 expression. Mechanistically, we find that Med1 enriched in these EVs can directly bind to the promoter region of the IL‐21 gene thus activating IL‐21 transcription in Tregs. Moreover, we confirm that suppressing Med1 accumulation in EVs from activated pulmonary ECs can reverse Treg differentiation, and alleviate lung inflammation. Finally, we observe a significant increase of EVs carrying Med1 in the BALF of patients with ARDS. Taken together, this study identifies that EV‐mediated pulmonary endothelium‐Treg communication is crucial for Treg suppression in ARDS and may provide potential therapeutic targets for the treatment of this fatal clinical syndrome.
科研通智能强力驱动
Strongly Powered by AbleSci AI